Review
doi: 10.1055/s-0029-1222570.
Epub 2009 May 6.
[The value of incretin based therapies]
[Article in
German]
Affiliations
- PMID: 19421931
- DOI: 10.1055/s-0029-1222570
Item in Clipboard
Review
[The value of incretin based therapies]
[Article in
German]
Dtsch Med Wochenschr.
2009 May.
No abstract available
Similar articles
-
[DPP-4 inhibitors in clinical use. Therapy without the risk of hypoglycaemia].Pharm Unserer Zeit. 2010 Mar;39(2):114-8. doi: 10.1002/pauz.201000358. Pharm Unserer Zeit. 2010. PMID: 20196038 Review. German. No abstract available.
-
Choosing among the incretin agents and why it matters.J Fam Pract. 2010 May;59(5 Suppl):S30-5. J Fam Pract. 2010. PMID: 20544056 No abstract available.
-
[Incretin related agents for treatment of diabetes mellitus].Nihon Naika Gakkai Zasshi. 2009 Apr 10;98(4):809-16. doi: 10.2169/naika.98.809. Nihon Naika Gakkai Zasshi. 2009. PMID: 19472544 Review. Japanese. No abstract available.
-
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.Expert Opin Investig Drugs. 2008 Jun;17(6):845-53. doi: 10.1517/13543784.17.6.845. Expert Opin Investig Drugs. 2008. PMID: 18491986 Review.
-
[Therapeutic use and adverse events of incretin-related drugs].Nihon Rinsho. 2012 May;70 Suppl 3:699-702. Nihon Rinsho. 2012. PMID: 22768601 Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
